Guidance of the Scientific Committee on Use of the benchmark dose approach in risk assessment

This output is superseded by a newer version
First published in the EFSA Journal
29 June 2009
Adopted
26 May 2009
Last Updated
30 November 2009. This version replaces the previous one/s.
Type
Guidance

Abstract

No abstract available

Panel members at the time of adoption

Susan Barlow, Andrew Chesson, John D. Collins, Albert Flynn, Anthony Hardy, Klaus-Dieter Jany, Ada Knaap, Harry Kuiper, John-Christian Larsen, David Lovell2, Pierre Le Neindre, Jan Schans, Josef Schlatter, Vittorio Silano, Staffan Skerfving, Philippe Vannier.
doi
10.2903/j.efsa.2009.1150
Question Number